Lab Information
Sasha Bernatsky (MD/PhD)
Senior ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Keywords
Pharmacoepidemiology • systemic lupus • rheumatic disease • drug safety and effectiveness • air pollutionResearch Interests
My research focuses mainly on outcomes in rheumatic diseases, pharmacoepidemiology, and air pollution’s effects on health.Team Members
| Name | Position |
|---|
Latest Publications
- Caricchio, R., Bell, S., Bernatsky, S., Dall'Era, M., Goddard, D., Kalunian, K., Kim, A. H. J., Koumpouras, F., Rubio, J., Saxena, A., Sheikh, S. & Lupus Clinical Investigators Network (2025). A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases. ACR open rheumatology, vol. 7, p. e70139.
- Bérard, A., Sheehy, O., Kaul, P., Eltonsy, S., Walker, M., Hawken, S., Bernatsky, S., Pugliese, M., Barrett, O., Savu, A. & Dragan, R. (2025). COVID-19 Infections Still Occur: How Do Pregnant and Non-Pregnant Individuals Compare? A Study from the Canadian Mother-Child Initiative on Drug Safety in Pregnancy (CAMCCO). International journal of environmental research and public health, vol. 22.
- Moghaddam, S. M., Zhao, N. & Bernatsky, S. (2026). Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus: A Review. Rheumatic diseases clinics of North America, vol. 52, p. 47-64.
- Flatman, L. K., Beauchamp, M.-E., St-Pierre, Y., Malhamé, I., Bérard, A., Bernatsky, S. & Vinet, É. (2025). Tumor Necrosis Factor Inhibitors and Risk of Serious Infections in Pregnant Women With Chronic Inflammatory Diseases. ACR open rheumatology, vol. 7, p. e70117.
- Zhao, K., Yang, A. Y., Oualkacha, K., Zeng, Y., Klein, K., Hudson, M., Colmegna, I., Bernatsky, S. & Greenwood, C. M. T. (2024). A novel high-dimensional model for identifying regional DNA methylation QTLs. Biostatistics (Oxford, England), vol. 26.
- Zhao, N., Smargiassi, A., Chen, H., Choi, M. Y., Fritzler, M. J., Touma, Z., Antonio Aviña-Zubieta, J. & Bernatsky, S. (2025). Fine particulate matter air pollution and anti-nuclear antibodies. Rheumatology (Oxford, England).
- McDonald, S., Teng, J., Yang, C., Barraclough, M., Alarcon, G. S., Askanase, A. D., Bernatsky, S., Clarke, A. E., Costedoat-Chalumeau, N., Fu, Q., Gladman, D. D., Hanly, J. G., Legge, A. C., Isenberg, D., Kalunian, K., Kamen, D. L., Petri, M. A., Rahman, A., Sun, C., Li, T., Urowitz, M., Voskuyl, A., Wallace, D. J., Zhang, J. & Bruce, I. N. (2025). Towards a minimal core dataset for systemic lupus erythematosus studies. Lupus science & medicine, vol. 12.
- Baniña, M. C., Prabhune, R., Charles, C., Colmegna, I., Hudson, M., Bernatsky, S. & Peláez, S. (2025). Understanding patient and physician perspectives regarding innovative research in rheumatoid arthritis. The Journal of rheumatology.
- Bernatsky, S. & Zhao, N. (2025). Reply to Letter to the Editor: "Systemic autoimmune rheumatic disease risk is associated with long-term exposure to fine particulate matter". Arthritis & rheumatology (Hoboken, N.J.).
- Lee, J. J. Y., Bernatsky, S., Benchimol, E. I., Kwong, J. C., Li, Q., Yeung, R. S. M. & Widdifield, J. (2025). Safety and health care utilization following COVID-19 vaccination (BNT162b2) among children and youth with juvenile idiopathic arthritis and inflammatory bowel disease: A population-based study. Paediatrics & child health, vol. 30, p. 305-311.
See also









